COLORADO SPRINGS — Pediatric nonalcoholic fatty liver disease is strongly associated with multiple cardiovascular risk factors, often in excess of clinical thresholds for considering pharmacotherapy, Dr. Stephen Cook said at a conference of the American Heart Association.